BioImagene
Company

Last deal

$26M

Amount

Series D

Stage

19.08.2008

Date

2

all rounds

$30.2M

Total amount

General

About Company
BioImagene provides digital pathology solutions for clinical diagnostics and drug discovery applications.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2003

Number of employees

Company Type

For Profit

Last funding type

Series D

IPO status

Private

Description

The company offers integrated hardware and software systems for pathology laboratories to acquire, view, share, manage, archive, and analyze tissue images. Its products include IHC algorithms for various cancers, an input device for pathologists to manipulate digital images of slides, and digital slide scanners for digital pathology applications such as image analysis and telepathology. BioImagene serves a range of clients, including cancer research laboratories, academic medical centers, community hospitals, and pharmaceutical companies.
Contacts